A groundbreaking blood test for concussion diagnosis in older adults has been developed by researchers at Monash University and The Alfred. This innovative approach, published in JAMA Network Open, utilizes a protein called glial fibrillary acidic protein (GFAP) as a reliable indicator of concussion in adults over 60. The study's findings are particularly significant given the challenges of diagnosing concussion in older Australians, where symptoms often overlap with normal aging or pre-existing medical conditions.
The research team analyzed blood samples from 89 patients aged 60 to 84 who had experienced falls or head injuries. They discovered that elevated levels of GFAP were present in patients who had sustained a concussion, compared to those who had not. This objective and reliable measure has the potential to revolutionize the diagnostic process, reducing the ambiguity currently surrounding concussion in older adults.
Dr. Gershon Spitz, lead author from the Monash School of Psychological Sciences, emphasizes the importance of this development. He states, 'There is a lot of ambiguity in the current diagnostic process, and doctors often rely on patient self-reporting, which can be biased. When dealing with potential head injuries, cognitive issues like loss of consciousness or memory loss can further complicate accurate diagnosis. However, GFAP provides an objective and reliable measure that we believe will be a game-changer.'
Sandy Shultz, senior author from the Monash School of Translational Medicine, highlights the potential impact of this test beyond hospitals. She says, 'Timing is critical for concussion treatment. This test could become a vital tool for paramedics and emergency responders, enabling swift and effective intervention.'
The development of this blood test is a significant step forward in concussion diagnosis, offering a more accurate and timely approach, particularly for older adults who are at higher risk of head injuries. As the research continues, the potential for widespread implementation and its impact on patient care and outcomes is immense.
